XENSE INC
Xense Inc. is focused on advancing medical imaging through the development of next-generation CT and X-ray technologies and AI-driven imaging solutions. The company’s mission is to deliver highly detailed, accurate, and rapid diagnostic imaging, with the goal of transforming healthcare by enhancing the precision, speed, and accessibility of radiological diagnosis, intervention, and monitoring. Xense has filed and been granted multiple patents in imaging hardware, algorithms, and supporting technologies, though its primary products are currently in development and not yet FDA approved for commercial use.
Industries
N/A
Nr. of Employees
small (1-50)
Products
uTomo Technology Platform
A platform enabling compact, ultralow-radiation CT and X-ray imaging with integrated AI for medical diagnostics. Intended to replace traditional CT, x-ray, fluoroscope, and densitometer devices.
uTomo Technology Platform
A platform enabling compact, ultralow-radiation CT and X-ray imaging with integrated AI for medical diagnostics. Intended to replace traditional CT, x-ray, fluoroscope, and densitometer devices.
Services
Solutions for OEMs to integrate advanced imaging platforms into products, including consulting and licensing.
Solutions for OEMs to integrate advanced imaging platforms into products, including consulting and licensing.
Expertise Areas
- Digital medical imaging
- Radiology AI solutions
- Compact CT/X-ray technology development
- OEM imaging technology integration
Key Technologies
- Tomographic imaging
- Low-dose X-ray imaging
- AI-assisted diagnostics
- Digital flat panel detectors
News & Updates
Xense is showcased on CNBC's Advancements TV in a segment focusing on state-of-the-art technologies for imaging and diagnostics.
US Patent No. US20260007382 was granted for platform technology and its first-generation AI-enabled CT imaging technology.
Interview with Dr. Justin Shafa discusses the future impact of next-generation imaging technology on neuroradiology and stroke diagnosis.
Interview with Dr. Giora Weisz highlights the benefits of advanced imaging systems for cardiovascular diagnosis and intervention.
Xense is showcased on CNBC's Advancements TV in a segment focusing on state-of-the-art technologies for imaging and diagnostics.
US Patent No. US20260007382 was granted for platform technology and its first-generation AI-enabled CT imaging technology.
Interview with Dr. Justin Shafa discusses the future impact of next-generation imaging technology on neuroradiology and stroke diagnosis.
Interview with Dr. Giora Weisz highlights the benefits of advanced imaging systems for cardiovascular diagnosis and intervention.